Changes in climate constitute a reality that, according to recent projections, is going to worsen in the coming years.1 Increasing air pollution and climate change have an impact on respiratory health and mortality where climate change represents a massive direct threat to respiratory health by promoting or aggravating respiratory diseases or indirectly by increasing exposure to risk factors for respiratory diseases.

Overall Aim:
To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them to provide better patient advice and self-care.

Learning objectives:

- Identify the changes in climate as well as the interrelationship between climate change and air pollution
- Understand the impact of climate change and air pollution on health particularly respiratory health
- Understand how climate change and air pollution affect people living in low- and middle-income countries
- Know the intervention, treatment and management strategies including self-care measures to minimize the impact on respiratory health
- Recognize the role pharmacists must play to support better health care delivery and patient care

Moderator:
- Gonçalo  Sousa Pinto, Lead for practice development and transformation, FIP Spain

Panelsists:
- Kian Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College London, United Kingdom
- Sundeep Salvi, Founder and Director The Chest Research Foundation, India
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia
- Ravijyot Saggu, Lead clinical pharmacist and CPhO clinical fellow ’21/’22, NHS England, UK

Overall Aim:
To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them provide better patient advice and self-care.

Learning objectives:
• Identify the sources of indoor air pollution and its increasing threat to health
• Understand the short- and long-term impact of indoor air pollution particularly on children
• Understand clinical, pharmacological, and non-pharmacological treatments including self-care measures to minimize the impact of air pollution on respiratory health
• Illustrate how advocacy can impact behavior change to support adoption of better self-care practices aimed at reducing health impact of air pollution.

Moderator:
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia

Facilitator:
- Nour Eltahla, FIP Projects Coordinator for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia

Panelists:
- Lidia Morawska, Director International Laboratory for Air Quality and Health (WHO CC for Air Quality and Health), Queensland University of Technology, Australia
- Gary WK Wong, Professor and honorary consultant, Department of Paediatrics, Chinese University of Hong Kong, Hong Kong
- Tyler Knowlton, Director of Communications, Communities, and Partnerships Plume Labs, France

There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium will mark the United Nations' International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.

learning objectives:
- Identify prevailing barriers limiting the deployment of services to reduce the impact of air pollution by community pharmacists.
- Describe facilitators and enablers that can influence air pollution service delivery by community pharmacists.
- Understand the policy and regulatory landscape that needs to be established to promote air pollution mitigation services by community pharmacists.

Moderator:
- Lars-Åke Söderlund, President, Community Pharmacy Section FIP, Sweden

Panellists:
-Ema Paulino, Professional Secretary FIP, Portugal 
-Paul Sinclair, Chair of the Board of Pharmaceutical Practice FIP, Australia
-Deana Lykins, Policy & Government Affairs Consultant The Clean Breathing Institute, USA
-Anna Murphy, Consultant Respiratory Pharmacist
University Hospitals of Leicester NHS Trust, United Kingdom
-Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association (KNMP), The Netherlands

Health systems and health care professionals are called upon to address and mitigate the impact of air pollution on people’s health and quality of life. There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. This webinar will provide examples of services that pharmacists can deliver to support better breathing.

Learning objectives:
- Describe the role that pharmacists can play in mitigating air pollution in the community.
- Identify the different tools available to pharmacists to enable the reduction of the impact of air pollution in the community.
- Understand the various arrays of services that community pharmacists can employ in supporting better breathing.

Modetaror:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden

Panellists:
- Daniella Munene, CEO Pharmaceutical Society of Kenya - Kenya
- Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association - The Netherlands
- Emilio Santoro, Medical Affairs Principal Scientist, Respiratory and Skin Health, Global Category, GSK Research & Development - United Kingdom

Air pollution needs to be addressed urgently and not only as an environmental and ecological threat, but also as a direct threat to health. This webinar will describe the multiple ways in which air pollution can be harmful to health. Understanding such impacts is essential so that professional services and interventions by pharmacists can be developed to address this global threat.

Learning objectives:
- Identify the various ways that outdoor and indoor air pollution impacts on human health
- Understand the short-term and long-term impact of air pollution on health
- Illustrate how air pollution might change the type of professional services offered by pharmacists
- Describe the different roles pharmacists can play in addressing air pollution

Moderator:
Prof. Rula Darwish, University of Jordan - Jordan

Panellists:
Prof. Gary WK Wong, Professor and honorary consultant, Department of Paediatrics Chinese University of Hong Kong - Hong Kong
Prof. Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College - UK